Clinical trial
Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2…
NCT00168519 · Baker Heart Research Institute, Other · Completed
Key facts
| NCT number | NCT00168519 |
|---|---|
| Title | Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes |
| Official title | Contraction Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes |
| Lead sponsor | Baker Heart Research Institute, Other |
| Collaborators | National Health and Medical Research Council, Australia Hoffmann-La Roche Industry Life for a Child Program, Diabetes Australia |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | nitroprusside, pentalong, imdur, AICAR, isoptin |
| Enrollment | 40 |
| Start date | Oct 1, 2002 |
| Completion | Apr 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 15, 2009 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: